EU wants to withdraw all dextropropoxyphene products
This article was originally published in Scrip
Executive Summary
All marketing authorisations for dextropropoxyphene-containing products should be withdrawn in the EU because of the risk of intentional or accidental overdose, the EU's CHMP has recommended. The risk of overdosing only became evident when data from national poison centres and mortality statistics throughout the EU were analysed in depth, the committee adds.